Background We analyse whether the tuberculin skin test is a good survival marker in a cohort of pulmonary tuberculosis patients with HTV infection (PTB/fflV). In all, 494 PTB/HTV patients were enrolled in Barcelona (Spain) between January 1992 and December 1994 in the Tuberculosis Program of Barcelona. The main data problem was the large proportion of missing values in the covariates percentage of T CD4+ lymphocytes and the tuberculin test results: only 157 patients (31.8%) had both covariates recorded.
resources to carry out laboratory tests such as the determination of lymphocyte subsets or the viral load. This is one of the reasons why the use of clinical parameters, with inexpensive and simple tests (e.g. the tuberculin skin test) or straightforward and practical laboratory markers, would be desirable for estimating survival probability.
Survival studies on TB/HTV patients are few and based on complete data; that is to say, without taking into account missing data. 4 ' 610 However, when the problem one wishes to analyse depends on the behaviour of covariates with missing data, the treatment of such data is crucial both for conclusions that may be reached and for decisions that must be taken based on those conclusions. The aim of this work, therefore, is to carry out a survival study by analysing the predictive role played by variables such as the tuberculin skin test and the precentage of T CD4+ lymphocytes, which both present a large amount of missing data. To this end, bootstrap methodology" and a multiple imputation scheme 12 ' 13 will be applied as an initial approach to the methods of treating variables with missing data.
Methods
In Barcelona, both acquired immunodeficiency syndrome (AIDS) and TB are monitored actively by the Epidemiology Service of the Municipal Institute of Health. This service gathers data provided by doctors, as well as results from microbiological analysis, hospital discharges, mortality data and linkage between AIDS and TB Registers.
Definitions

Tuberculosis
A patient was considered to be tuberculous if he or she had been receiving chemotherapy treatment for TB, and if such treatment had been administered for a pre-established period of time, unless it had been interrupted by either the appearance of secondary effects or by death of the patient. In cases of pleural TB, anatomical, pathological and/or enzymatic criteria 14 ' 15 were also considered.
Tuberculin skin test
This was performed according to the Mantoux technique, applying 2 TU of PPD RT-23 intradermally, and a reading taken between 48 to 72 h. Indurations of s«5 mm were considered positive. 14 
Human Immunodeficiency Virus
A patient was considered HIV-infected if the ELISA (enzymelinked immunosorbent assay) test was positive at the time of TB diagnosis, and if this result was confirmed by Western blot. 16 
Data
The study population was HIV-infected patients with pulmonary tuberculosis (PTB), with or without extrapulmonary infection, resident in Barcelona city, and diagnosed between 1 January 1992 and 31 December 1994. If the culture identified an atypical mycobacteria, the patient was excluded from the study. Patients with a medical record of TB were included only if they had received no treatment against TB for more than a year.
The survival time for each patient was established as the number of days between the date of TB diagnosis and death, or 31 December 1994 for those patients who were still alive on this date. Consequently, those patients alive when the study was concluded, or when loss to follow-up occurred, are considered to be right censored because death has not been observed.
Study variables
In addition to the survival time and vital status, other variables were recorded for each patient: sex, age at the TB diagnosis, district of residence, prison history, HIV transmission group, alcohol addiction, homelessness, result of tuberculin test (PPD: negative = 0, positive =1), percentage of lymphocyte subsets (CD4and CD8), microbiological results, radiological pattern and site of TB.
The CD4 and CD8 variables, measured as percentages, were chosen rather than the respective absolute counts because they have lower variability and also because it has been shown that a high correlation exists between the absolute number of T CD4+ and percentage of T CD4+.
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Missing data
The percentage of missing data was in general less than 10%. However, there was a large amount of missing data in both the variable CD4 (38.8%) and in the PPD variable (50.4%). Only 31.8% of the data were complete for these two variables. The methodology we set forth in the following subsection enabled us to make full use of the information found in the other 68.2%, where missing data were present.
Statistical analysis
Analysis was carried out in two stages: 18 (a) univariate and multivariate analysis of the complete data, and (b) the treatment of missing data and the parametric estimate by multiple imputation.
(a) In the complete data univariate analysis, the KaplanMeier method was used to estimate the survival curves, and the Cox regression model was used to analyse the role of the various categories within the covariates. For each variable, the model was validated by studying the significance of the interaction of the variable with time, and with the logarithm of time, assuming the hypothesis of proportional hazards if such interactions are not significant. For the multivariate analysis, the Cox regression model was set with those covariates that were significant from the univariate analysis.
We defined the observed subsample as that consisting of the 157 (31.8%) patients for whom the CD4 and PPD values were available. We dichotomized the CD4 variable as 0 for those patients with a percentage of T CD4+ cells =S14% (corresponding to 200 T CD4+ cells/mm 3 , which is the index below which a patient is judged to have AIDS); 16 and 1 otherwise.
To obtain more predse estimates, we fit a Weibull regression model for each immunosuppression level. The hazard function at moment t for a patient with PPD value in the tuberculin test is given by the expression The fitting, graphically validated, provides, among others, the relative n-percentile (0 =£ n =* 1) estimate for a positive (b) It is assumed that the response process of the covariates CD4 and PPD is Missing At Random (MAR), 12 i.e. that the probability of observing the values of CD4 and PPD does not depend on the missing values of these variables. This assumption has been graphically validated.
Let XQ denote the initial incomplete sample, and 9 the relevant parameter. To estimate 0, we proceed according to the following scheme: , we obtain a bootstrap replica of the initial sample XQ, which we denote by X^, then, by means of the bilinear imputation method," we get a completed sample, X^ and, finally, using a Weibull regression model, we obtain the corresponding estimate of 0, Q b . This procedure enabled us to obtain 200 estimates (3l---"02OO-The estimator we proposed by multiple imputation is
with a variance composed of two parts: the /nfravariance due to the imputation itself and the irtfrrvariance due to the different imputations. ' So, we obtained confidence intervals for the relative percentiles between groups.
For the basic statistical analysis, SPSS-PC 20 and EGRET 21 software were used. The bootstrap sampling and the bilinear imputation method have been implemented in PASCAL language, and carried out on a Sun SPARC work station in a UNIX environment.
Results
Complete data analysis
The cohort under study was made up of 494 TB/HIV-infected patients. (range 1-86%), the first and third quartile were 5% and 18% respectively, and the mean was 14% (SD: 13.1%). Overall 63.8% (315 cases) were censored and, among them, only 23 (4.7%) were lost to follow-up. The median follow-up time for the censored patients was 455 days. Figure 1 shows the Kaplan-Meier survival estimates according to immunosuppression level and the result of the tuberculin skin test for the observed subsample. Note that while the first quartile and the median can be evaluated for the most immunosuppressed group and for the negative tuberculin group, for the other two groups the median cannot be explicitly derived. Table 1 presents the results of the univariate Cox model. It can be observed that only the T CD4+ percentage, the result of the tuberculin test and age are significant.
For the multivariate analysis in the observed subsample (N = 157), we only considered the covariates CD4 (continuous and categorized), PPD and age, and only the dichotomized CD4 variable was found to be significant ( Table 2 ). The estimated relative hazard was 0.3198 (95% CI: 0.17-0.60) for the least immunosuppressed group with respect to the most immunosuppressed group.
Using the same model, and based on the 302 patients who had an observed %CD4 value, independently of the observation of the PPD covariate, we were able to estimate a relative hazard similar to that mentioned above (RH = 0.3537; 95% CI : 0.23-0.55).
If we divided the observed subsample into rwo groups according to the immunosuppression level, and if in each group we analysed the effect of the PPD, CD4 and age covariates, we observed that in the most immunosuppressed group there was a significant relative hazard (0.3657, 95% CI : 0.13-1.02; P = 0.054) for patients with positive tuberculin, compared to those with negative tuberculin. However, in the least immunosuppressed group, and after adjusting for all the mentioned covariates, there was no significant difference between the cases (Table 3) . After fitting a Weibull model, that had been graphically validated, for the whole sample the maximum likelihood estimate of P and a, before including the covariates in the model, is 7.364 and 1.411, respectively. Analogously, for the observed subsample we obtained values of 7.318 and 1.326, respectively. Table 3 also shows the P and a estimates according to the level of immunosuppression, both before and after recording the effect of the PPD covariate. For the most immunosuppressed group we verified the protective effect of positivity in the tuberculin skin test by estimating the PPD coefficient of P, P, =8.100-6.681 = 1.419 (SE: 0.739, P = 0.055) and a constant relative percentile value of pR = 4.1329 (95% CI : 0.97-17.59), whereas the PPD covariate was not significant in the least immunosuppressed group. The corresponding percentile estimates, expressed in days, for the different relevant subsamples can be seen in Table 4 . So, for example, the 20% percentile was estimated at 190 days for the whole sample, and at 206 days for the observed subsample, before any covariate adjustments are made. Nevertheless, if we consider the most immunosuppressed group, and we adjust for the tuberculin test, we estimate the 20% percentile at 101 days for the negative tuberculin patients, and at 417 days for those who were positive. Finally, in the least immunosuppressed group, the information furnished by the tuberculin test was not significant, and we were able to estimate this percentile at 611 days. Figure 2 shows both the estimate of the survival function for each of the different relevant subsamples, and the time elongation between categories; one may observe that the group showing greatest survival is that made up of the most immunosuppressed patients with positive tuberculin tests.
Missing data analysis After obtaining 200 completed bootstrap replicas (N = 494) and estimating the coefficients (P t and a { ) of the PPD variable for each one, and for each immunosuppressed level, while the scale parameter, P t , is found to be significant for most of the replicas in the most immunosuppressed group, the shape parameter, a,, is not. It was therefore decided to fit a Weibull model dependent on a scale Pj parameter for each of the 200 samples. In this way, 200 P, estimates were obtained with the average proposed as estimator. An analogous process was carried out for the least immunosuppressed group. In this case the shape parameter Oj was the parameter of greatest interest. Likewise, the average of the 200 a ] estimates are proposed as the shape parameter estimator. Table 5 shows the results of this methodology. Specifically, the P| estimate differs significantly from 0 for the most immunosuppressed patients, and we can estimate a constant relative percentile 5.48 (P = 0.079) for the positive tuberculin group compared with the negative tuberculin group. Furthermore, the O] estimate does not differ significantly from 0 for the least immunosuppressed patients. Finally, Figure 4 shows the confidence intervals for the aforementioned relative percentiles. The results obtained for the two immunosuppression levels are presented separately in Table 6 .
Discussion
Missing data constitute a frequent and on occasions unavoidable problem in epidemiological studies, and therefore recourse must be made to sophisticated methodologies. That is the case in this study. For this reason it is worthwhile considering the following two elements: the use of the MAR hypothesis, and the precision of the corresponding estimators.
In our study, if we analyse survival from the point of view of the absence or presence of the CD4 variable, Figure 3a ) suggests, graphically (and validated according to a Cox model) that the distribution of patients for whom the CD4 variable is available is basically the same as that for those whom it is unavailable. In this way we would thus obtain a MCAR response pattern.
If the survival study is carried out assuming that the tuberculin test is positive, negative or even unavailable, Figure 3b ) and the corresponding Cox modelling show that there are no significant differences between the negative tuberculin group and the not available tuberculin group. However, differences do exist between these two groups and the positive tuberculin group. In this case, the PPD observed values are not a random subsample of the potential PPD values, although they are random within the categories defined by the survival times. In other words, since the missing data distribution in the PPD variable depends on the survival time, the response probability in the PPD variable is the same for all patients for whom the same survival time has been observed. In this case, the response mechanism can be considered ignorable. 12 Thus, inferences based directly on the observed values of the PPD variable cannot be made since they are not representative. Nevertheless, inferences can be made from the conditional probabilities of the PPD variable, given the observed variables. In particular, methods based on maximum likelihood, which is the method used in this work, are valid, and the said inferences take into account the information referring to the non-observation of the PPD variable at some levels of the survival time variable.
If we consider the precision of the estimators resulting from the new methodology, two points are worthy of note; on one hand, at each step of the imputation we recover the size of the initial sample (N = 494), and this facilitates greater precision in the estimates. However, the added variance due to the methodology in each bootstrap replica, and that due to the multiple imputation process itself, must be taken into account.
In recent years the relation existing between a series of demographical, clinical and immunological factors in AIDS patient prognosis has become increasingly dear. 22 Nevertheless, studies based on TB/HFV are scarce, and up till now somewhat inconclusive, since the number of cases available for study has been small. In this study, it is important to point out the high number of patients with PTB studied and the survival time (a median of 28.8 months)-greater than that recorded in other studies (median between 12 and 24 months). 22 This difference could well be accounted for by the fact that TB was detected in the early stages of HTV infection, 23 which would represent a lead time between 6 and 9 months in AIDS diagnosis. 24 ' 25 Moreover, younger AIDS patients have a greater chance of survival. 22 ' 26 ' 27 It is well worth noting that more than 75% of all patients studied were rVDU, and it is well known that IVDU patients are often younger than people belonging to other HIV transmission groups. 2 *" 30 Furthermore, after fitting different variables such as HIV transmission group, presence of opportunistic diseases and therapy against HTV, TB is an accelerating factor in the progression of HIV/AIDS, and patients with TB have a shorter survival than HIV patients who do not have TB. 31 However, TB preventive therapy delays the appearance of other illnesses in HIV-infected patients, while at the same time prolonging survival. 32 Consequently, it is important to note that early diagnosis and treatment of TB is not only beneficial for the community at large, preventing further cases of infection, but also improves the quality of life and extends the survival time of patients already infected. To this end, in communities where HIV/Af. tuberculosis coinfection is high, such as the IVDU group, 33 it is necessary to promote programmes of chemoprophylaxis and chemotherapy together with the administration of methadone to ensure effective treatment and to bring down the incidence of TB and AIDS, as well as to reduce the contagiousness of TB patients. 34 " 36 Previous survival studies show that patients with a high percentage of T CD4+ have a better prognosis. 6 ' 37 In this study, a positive result in the tuberculin test proved to be a better marker for survival prediction than the CD4+ percentage in patients with a T CD4+ lymphocyte percentage lower than 14%, which would indicate that the activity of T CD4+ lymphocytes, evaluated indirectly by means the tuberculin test, is more important than the T CD4+ percentage. In this regard, various authors have suggested that the presence of lymphocytes with Thl cytokines pattern (H.-2 and IFN-y, among others) of production would increase chances of survival for HTV positive patients, since these Thl lymphocytes are the ones involved in immunity-delay phenomena such as the tuberculin test. Before the HIV epidemic, 90% of PTB had a positive tuberculin test. 39 This suggests that the high prevalence of negative tuberculin test in TB HIV-infected patients observed in our study is due to the HIV immunodepression. Therefore, a negative tuberculin test without CD4 data is indicative of poor prognosis in these patients (Figure 3b) .
The results presented here concur with those of other studies which point to the possibility of carrying out an estimate of survival probability in TB patients without necessarily using T CD4+ lymphocyte counts. 4 ' 40 As can be seen from this study, the tuberculin skin test can play an important role, particularly when lymphocyte subsets or viral load, for example, are still unavailable, as is the case in countries with the highest levels of HTV/Af. tuberculosis coinfection; countries which, moreover, due to their economic situation, are unable to draw upon the technical resources necessary for specific laboratory tests.
